Stratec SE (LON:0RAR)
25.73
+0.08 (0.29%)
At close: Sep 4, 2025
Stratec SE Company Description
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally.
The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers.
It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software.
The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Stratec SE
Country | Germany |
Founded | 1979 |
Industry | Medical - Equipment & Services |
Sector | Healthcare |
Employees | 1,387 |
CEO | Marcus Wolfinger |
Contact Details
Address: Gewerbestrasse 37 Birkenfeld, 75217 Germany | |
Phone | 49 7082 7916 0 |
Website | stratec.com |
Stock Details
Ticker Symbol | 0RAR |
Exchange | London Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | DE000STRA555 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Marcus Wolfinger | Chairman of Board of Management and Chief Executive Officer |
Dr. Robert Siegle | Director of Finance and Human Resources and Member of Board of Management |
Dr. Claus Vielsack | Director of Product Development and Member of Board of Management |
Hermann Leistner | Founder and Advisor |
Jan Keppeler | Head of Investor Relations, Sustainability and Corporate Communications |
Andre Loy | Director of Corporate Communications |
Roland Utz | Head of Supply Chain Management and Senior Vice President |